NCT00650624 - A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan) | Biotech Hunter

Enrollment

416

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

January 31, 2004

Conditions

Osteoarthritis, Knee

Interventions

DRUG

valdecoxib

valdecoxib 5 mg tablet by mouth once daily in the morning for 6 weeks

DRUG

valdecoxib

valdecoxib 10 mg tablet by mouth once daily in the morning for 6 weeks

DRUG

valdecoxib

valdecoxib 20 mg tablet by mouth once daily in the morning for 6 weeks

DRUG

placebo

placebo tablet by mouth once daily in the morning for 6 weeks

Trial Locations (22)

Pfizer Investigational Site, Funabashi

Pfizer Investigational Site, Sakura

Pfizer Investigational Site, Chikushi-gun

Pfizer Investigational Site, Iizuka

Pfizer Investigational Site, Kurume

Pfizer Investigational Site, Yame

Pfizer Investigational Site, Chitose

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Kamakura

Pfizer Investigational Site, Yokohama

Pfizer Investigational Site, Isahaya

Pfizer Investigational Site, Hirakata

Pfizer Investigational Site, Kanzaki-gun

Pfizer Investigational Site, Karatsu

Pfizer Investigational Site, Ogi-gun

Pfizer Investigational Site, Itabashi-ku

Pfizer Investigational Site, Setagaya-ku

Pfizer Investigational Site, Shinjuku-Ku

Pfizer Investigational Site, Taito-ku

Pfizer Investigational Site, Yoyogi Shibuya-ku

Pfizer Investigational Site, Saga

Pfizer Investigational Site, Tokyo